Pamidronate
Drug Status in USA : Approved
Drug Status in Canada : Approved
Indication : Why is this medication prescribed?
Hypercalemia of malignancy. Pagets disease.
Contraindication: What are the special precautions to be followed?
Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Hypersensitivity. Pregnancy.Other Precaution to be observed while taking this medication
May increase the risk of heart failure in patients with cardiac disease. Lactation, Infuse slow to reduce risk of adverse effects.
What are possible side effects of this medication ?
Fluid overload. Generalized pain. Hypertension. Abdominal pain. Anorexia. Constipation. Nausea, vomiting. Super edit Urinary tract and chest infection. Anaemia. Hypokalemia. Hypomagnesemia. Hypophosphatemia. Arthralgia, myalgia, flu like symptoms. Acute renal and heart failure.
Drug Category/Class
- Bisphosphonates
- Bone Density Conservation Agents
- Drugs Affecting Bone Structure and Mineralization
- Drugs for Treatment of Bone Diseases
- Musculo-Skeletal System
- Bisphosphonates
| Prescribed | For the treatment of moderate or severe hypercalcemia associated with malignancy |
| Weight : | 235.0695 |
| Structure | Pamidronate |
 |
| Formula | C3H11NO7P2 |
Pamidronate has 19 Brands listed
Search Generic Drugs alphabetically